{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:09:51Z","timestamp":1745986191133,"version":"3.40.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"DOI":"10.7759\/cureus.83159","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:05:43Z","timestamp":1745906743000},"source":"Crossref","is-referenced-by-count":0,"title":["Mean Corpuscular Volume Is Not a Reliable Predictor of Iron Deficiency in Patients With Chronic Kidney Disease: A Post-Hoc Analysis of the BRIGHTEN Trial"],"prefix":"10.7759","author":[{"given":"Sayaka","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kagimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey AS","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, et al.. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005, 67:2089-100. 10.1111\/j.1523-1755.2005.00365.x","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"Bello AK","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, et al.. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024, 12:e382-95. 10.1016\/S2214-109X(23)00570-3","journal-title":"Lancet Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.03.020","article-title":"Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference","volume":"99","author":"Babitt JL","year":"2021","unstructured":"Babitt JL, Eisenga MF, Haase VH, et al.. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2021, 99:1280-95. 10.1016\/j.kint.2021.03.020","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) controversies conference","volume":"89","author":"Macdougall IC","year":"2016","unstructured":"Macdougall IC, Bircher AJ, Eckardt KU, et al.. Iron management in chronic kidney disease: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) controversies conference. Kidney Int. 2016, 89:28-39. 10.1016\/j.kint.2015.10.002","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/BF02598003","article-title":"Laboratory diagnosis of iron-deficiency anemia: an overview","volume":"7","author":"Guyatt GH","year":"1992","unstructured":"Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992, 7:145-53. 10.1007\/BF02598003","journal-title":"J Gen Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-017-0114-y","article-title":"2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease","volume":"3","author":"Yamamoto H","year":"2017","unstructured":"Yamamoto H, Nishi S, Tomo T, et al.. 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther. 2017, 3:1-46. 10.1186\/s41100-017-0114-y","journal-title":"Ren Replace Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.41","article-title":"Summary of recommendation statements","volume":"2","author":"KDIGO Anemia Work Group","year":"2012","unstructured":"KDIGO Anemia Work Group. Summary of recommendation statements. Kidney Int Suppl (2011). 2012, 2:283-7. 10.1038\/kisup.2012.41","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/35.4.499","article-title":"Age dependent changes in osmotic hemolysis of human erythrocytes","volume":"35","author":"Araki K","year":"1980","unstructured":"Araki K, Rifkind JM. Age dependent changes in osmotic hemolysis of human erythrocytes. J Gerontol. 1980, 35:499-505. 10.1093\/geronj\/35.4.499","journal-title":"J Gerontol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V60.6.1241.bloodjournal6061241","article-title":"Erythropoiesis, erythropoietin, and iron","volume":"60","author":"Finch CA","year":"1982","unstructured":"Finch CA. Erythropoiesis, erythropoietin, and iron. Blood. 1982, 60:1241-6. 10.1182\/blood.V60.6.1241.bloodjournal6061241","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00970116","article-title":"Mean corpuscular volume and mortality in patients with CKD","volume":"12","author":"Hsieh YP","year":"2017","unstructured":"Hsieh YP, Chang CC, Kor CT, Yang Y, Wen YK, Chiu PF. Mean corpuscular volume and mortality in patients with CKD. Clin J Am Soc Nephrol. 2017, 12:237-44. 10.2215\/CJN.00970116","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-021-00327-x","article-title":"Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume","volume":"7","author":"Onda K","year":"2021","unstructured":"Onda K, Koyama T, Kobayashi S, Ishii Y, Ohashi K. Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume. Ren Replace Ther. 2021, 7:10.1186\/s41100-021-00327-x","journal-title":"Ren Replace Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.323","article-title":"Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients","volume":"52","author":"Fishbane S","year":"1997","unstructured":"Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int. 1997, 52:217-22. 10.1038\/ki.1997.323","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-017-1427-4","article-title":"Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)","volume":"22","author":"Kato H","year":"2018","unstructured":"Kato H, Nangaku M, Hirakata H, et al.. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial). Clin Exp Nephrol. 2018, 22:78-84. 10.1007\/s10157-017-1427-4","journal-title":"Clin Exp Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli F","year":"2013","unstructured":"Locatelli F, B\u00e1r\u00e1ny P, Covic A, et al.. Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant. 2013, 28:1346-59. 10.1093\/ndt\/gft033","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-024-02497-4","article-title":"Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023","volume":"28","author":"Japanese Society of Nephrology","year":"2024","unstructured":"Japanese Society of Nephrology. Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clin Exp Nephrol. 2024, 28:473-95. 10.1007\/s10157-024-02497-4","journal-title":"Clin Exp Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00188-1","article-title":"Interpreting area under the receiver operating characteristic curve","volume":"4","author":"de Hond AAH","year":"2022","unstructured":"de Hond AAH, Steyerberg EW, van Calster B. Interpreting area under the receiver operating characteristic curve. Lancet Digit Health. 2022, 4:853-5. 10.1016\/S2589-7500(22)00188-1","journal-title":"Lancet Digit Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden WJ","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950, 3:32-5. 10.1002\/1097-0142(1950)3:1&lt;32::AID-CNCR2820030106&gt;3.0.CO;2-3","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.271.9.703","article-title":"Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group","volume":"271","author":"Jaeschke R","year":"1994","unstructured":"Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994, 271:703-7. 10.1001\/jama.271.9.703","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.834463","article-title":"Reticulocyte maturation and variant red blood cells","volume":"13","author":"Stevens-Hernandez CJ","year":"2022","unstructured":"Stevens-Hernandez CJ, Flatt JF, Kupzig S, Bruce LJ. Reticulocyte maturation and variant red blood cells. Front Physiol. 2022, 13:834463. 10.3389\/fphys.2022.834463","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6821.225","article-title":"Detection of functional iron deficiency during erythropoietin treatment: a new approach","volume":"304","author":"Macdougall IC","year":"1992","unstructured":"Macdougall IC, Cavill I, Hulme B, et al.. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ. 1992, 304:225-6. 10.1136\/bmj.304.6821.225","journal-title":"BMJ"},{"key":"ref21","article-title":"Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin","volume":"41","author":"Fialon P","year":"1993","unstructured":"Fialon P, Leaute AG, Sassier P, Vallot C, Wone C. Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin. Pathol Biol (Paris). 1993, 41:931-5.","journal-title":"Pathol Biol (Paris)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236132","article-title":"Prevalence of anemia in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)","volume":"15","author":"Sofue T","year":"2020","unstructured":"Sofue T, Nakagawa N, Kanda E, et al.. Prevalence of anemia in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020, 15:e0236132. 10.1371\/journal.pone.0236132","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-017-1468-8","article-title":"Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease","volume":"22","author":"Sato Y","year":"2018","unstructured":"Sato Y, Fujimoto S, Konta T, et al.. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease. Clin Exp Nephrol. 2018, 22:388-94. 10.1007\/s10157-017-1468-8","journal-title":"Clin Exp Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0312-9","article-title":"Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia","volume":"17","author":"Eriksson D","year":"2016","unstructured":"Eriksson D, Goldsmith D, Teitsson S, Jackson J, van Nooten F. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia. BMC Nephrol. 2016, 17:97. 10.1186\/s12882-016-0312-9","journal-title":"BMC Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215920","article-title":"Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: a prospective cohort study","volume":"14","author":"Yi SW","year":"2019","unstructured":"Yi SW, Moon SJ, Yi JJ. Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: a prospective cohort study. PLoS One. 2019, 14:e0215920. 10.1371\/journal.pone.0215920","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61235-5","article-title":"Nutritional iron deficiency","volume":"370","author":"Zimmermann MB","year":"2007","unstructured":"Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007, 370:511-20. 10.1016\/S0140-6736(07)61235-5","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01791-w","article-title":"Tips for erythropoiesis-stimulating agent treatment of renal anemia","volume":"24","author":"Tomosugi N","year":"2020","unstructured":"Tomosugi N, Koshino Y. Tips for erythropoiesis-stimulating agent treatment of renal anemia. Clin Exp Nephrol. 2020, 24:105-6. 10.1007\/s10157-019-01791-w","journal-title":"Clin Exp Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358125-mean-corpuscular-volume-is-not-a-reliable-predictor-of-iron-deficiency-in-patients-with-chronic-kidney-disease-a-post-hoc-analysis-of-the-brighten-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:05:44Z","timestamp":1745906744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358125-mean-corpuscular-volume-is-not-a-reliable-predictor-of-iron-deficiency-in-patients-with-chronic-kidney-disease-a-post-hoc-analysis-of-the-brighten-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.83159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}